Cardiol Therapeutics Statistics
Total Valuation
CRDL has a market cap or net worth of $124.37 million. The enterprise value is $113.15 million.
Important Dates
The last earnings date was Thursday, November 14, 2024, after market close.
Earnings Date | Nov 14, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
CRDL has 79.90 million shares outstanding. The number of shares has increased by 5.66% in one year.
Current Share Class | 79.90M |
Shares Outstanding | 79.90M |
Shares Change (YoY) | +5.66% |
Shares Change (QoQ) | +2.85% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 76.19M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/TBV Ratio | 16.11 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.49, with a Debt / Equity ratio of 0.02.
Current Ratio | 2.49 |
Quick Ratio | 2.32 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -159.53% and return on invested capital (ROIC) is -104.92%.
Return on Equity (ROE) | -159.53% |
Return on Assets (ROA) | -79.07% |
Return on Capital (ROIC) | -104.92% |
Revenue Per Employee | n/a |
Profits Per Employee | -$4.46M |
Employee Count | 6 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +85.30% in the last 52 weeks. The beta is 0.70, so CRDL's price volatility has been lower than the market average.
Beta (5Y) | 0.70 |
52-Week Price Change | +85.30% |
50-Day Moving Average | 1.97 |
200-Day Moving Average | 1.96 |
Relative Strength Index (RSI) | 28.78 |
Average Volume (20 Days) | 403,956 |
Short Selling Information
The latest short interest is 814,793, so 1.02% of the outstanding shares have been sold short.
Short Interest | 814,793 |
Short Previous Month | 991,569 |
Short % of Shares Out | 1.02% |
Short % of Float | 1.07% |
Short Ratio (days to cover) | 1.37 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -28.36M |
Pretax Income | -21.99M |
Net Income | -26.75M |
EBITDA | -28.11M |
EBIT | -28.36M |
Earnings Per Share (EPS) | -$0.39 |
Full Income Statement Balance Sheet
The company has $11.76 million in cash and $122,865 in debt, giving a net cash position of $11.64 million or $0.15 per share.
Cash & Cash Equivalents | 11.76M |
Total Debt | 122,865 |
Net Cash | 11.64M |
Net Cash Per Share | $0.15 |
Equity (Book Value) | 7.72M |
Book Value Per Share | 0.11 |
Working Capital | 7.64M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$19.20 million and capital expenditures -$19,125, giving a free cash flow of -$18.58 million.
Operating Cash Flow | -19.20M |
Capital Expenditures | -19,125 |
Free Cash Flow | -18.58M |
FCF Per Share | -$0.23 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |